Revenue: The sum of all revenue fields included for a company's operating activities.
COSCIENS Biopharma Inc. (CSCI) had Revenue of $9.59M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$9.59M |
$-15.31M |
|
$4.86M |
|
$4.73M |
|
$23.61M |
|
$-14.02M |
|
$-1.20M |
|
$-15.22M |
|
$-10.97M |
|
$-15.31M |
|
$-15.31M |
|
$-15.31M |
|
$-11.08M |
|
$-14.02M |
|
$-13.27M |
|
2.58M |
|
2.58M |
|
$-5.93 |
|
$-5.93 |
|
| Balance Sheet Financials | |
$23.98M |
|
$10.97M |
|
$11.09M |
|
$35.07M |
|
$7.22M |
|
-- |
|
$14.69M |
|
$21.91M |
|
$13.16M |
|
$13.16M |
|
$13.16M |
|
3.14M |
|
| Cash Flow Statement Financials | |
$-14.57M |
|
$25.08M |
|
$-0.59M |
|
$6.68M |
|
$16.39M |
|
$9.71M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.33% |
|
-146.27% |
|
-146.27% |
|
-138.44% |
|
-158.81% |
|
-159.69% |
|
$-15.73M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
1.81 |
|
3.88 |
|
94.08 |
|
-116.32% |
|
-116.32% |
|
-43.65% |
|
-116.32% |
|
$4.19 |
|
$-6.09 |
|
$-5.64 |
|